Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Global Pharmacogenomics Markets Report 2021-2026: Focus on Cardiovascular, Oncology, Respiratory and Inflammatory, Neurological and Psychiatric, & Health Management and Predictive Medicine | ||
By: PR Newswire Association LLC. - 12 May 2021 | Back to overview list |
|
DUBLIN, May 12, 2021 /PRNewswire/ -- The "Global Pharmacogenomics Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for pharmacogenomics should grow from $7.7 billion in 2021 to $12.7 billion by 2026 with a compound annual growth rate (CAGR) of 10.6% for the period of 2021-2026. Report Scope: This report provides an updated review of pharmacogenomics, including materials, equipment, and strategies, and identifies current and emerging applications for pharmacogenomic products. The report delineates the current market status for pharmacogenomics, defines trends, and presents growth forecasts for the next five years. The pharmacogenomics market is analyzed based on the following segments: technology, product type, end-user, application, and region. In addition, technological issues, including key events and the latest developments, are discussed. The analysis of current revenues for pharmacogenomics is followed by a detailed presentation of market growth trends, based on industry growth, technological trends, and regional trends. Pharmacogenomics is a group of technologies focusing on the application of genomic testing to determine drug response. This relatively new field of life sciences, which combines biology, pharmacology and medicine to develop new drugs and optimize their dosage, is bringing numerous advantages in healthcare, including personalized medicine, therapies with high specificity, remedies for rare and hard-to-cure diseases, and treatments with reduced side effects. The report has identified five main sectors in which pharmacogenomics finds current and potential applications: cardiovascular disease; neurological and psychiatric disorders; oncology; respiratory and inflammatory diseases; and health management and predictive medicine. This study provides an updated review of pharmacogenomic technologies, including materials, equipment, strategies, and applications. It also offers a detailed market analysis for pharmacogenomics by segment (technology, product type, end-user, application, and region), describing technical aspects and trends that will affect future growth of this market. Applications for oncology currently account for the largest share of the market. Within this segment, pharmacogenomic products are being used primarily for the treatment of breast, lung and blood cancer. The Report Includes:
Key Topics Covered: Chapter 1 Introduction
Chapter 2 Summary and Highlights Chapter 3 Market and Technology Background
Chapter 4 Technology
Chapter 5 Global Markets
Chapter 6 Global Industry Structure and Company Profiles
Chapter 7 Patent Analysis
For more information about this report visit https://www.researchandmarkets.com/r/wgqnku Media Contact: Research and Markets SOURCE Research and Markets |
||
|
||
Copyright 2021 PR Newswire Association LLC. | Back to overview list |